U.S. Influenza Diagnostics Market Is Projected To Grow Robustly By 2030
U.S. Influenza Diagnostics Market Summary The U.S. influenza diagnostics market size was valued at USD 179.9 million in 2022 and is expected to grow at a CAGR of 5.9% from 2023 to 2030. Recurring seasonal outbreaks of influenza remain the primary driver of the market, creating a consistent need for effective testing solutions. Increasing awareness among the population, widespread screening programs, and rapid advancements in diagnostic technologies are significantly contributing to market expansion. Influenza, being a highly contagious viral infection, spreads quickly in public places where infected individuals act as carriers, thereby fueling the demand for reliable diagnostic methods on a large scale. The growing prevalence of influenza cases in the U.S. is further accelerating market growth. According to the Centers for Disease Control and Prevention (CDC), the 2021-2022 influenza season caused around 9 million illnesses, 4 million medical visits, 10,000 hospitaliz...